May 24-26, 2018
25th Human Animal Bridging Society, Tsukuba Japan
Keynote Lecture on "Towards the Virtual Patient. Developing Predictive Models for CNS Drug Discovery and Development with Quantitative Systems Pharmacology"
June 14, 2018
Neuropsychiatric symptoms in Alzheimer's Disease, New York
Contribution "Using Quantitative Systems Pharmacology for re-purposing drugs for neuropsychiatric symptoms in Alzheimer's Disease"
June 17-22, 2018
Keystone meeting on Advances in Neurodegenerative Disease, Keystone, Colorado
Contribution "Why do so many amyloid trials fail? Analysis using Quantitative Systems Pharmacology platform"
July 20-25, 2018
Alzheimer Association International Conference Society Conference, Chicago, US
Oral presentation "MAPTA (MODELING ALLIANCE FOR SYSTEMS PHARMACOLOGY IN TAUOPATHIES). MODELING THE IMPACT OF TAU ON HYPEREXCITABILITY IN MCI"
Poster "MAPTA (MODELING ALLIANCE FOR SYSTEMS PHARMACOLOGY IN TAUOPATHIES). UNEXPECTED FINDINGS WITH A MODEL FOR ANTIBODY MEDIATED TAU CLEARING"
Poster "REVISITING FAILED CLINICAL TRIALS. APPLICATION OF QUANTITATIVE SYSTEMS PHARMACOLOGY TO THE IMPACT OF COMEDICATIONS, GENOTYPES AND AMYLOID STATUS ON SEROTONIN MODULATORS"
Oct 7-10, 2018
American Conference on Pharmacometrics, San Diego, US
Oral presentation on "QUANTITATIVE SYSTEMS PHARMACOLOGY APPLICATIONS IN CENTRAL NERVOUS SYSTEMS DISORDERS" in special session on QSP applications in CNS.
For a list of past events, please see ISB News.